Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage
• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies.
Gespeichert in:
| Autor*in: |
Meuleman, Tess [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2016 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
7 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The use of serum marker CA-125 in patients operated because of endometriosis - Georgievska, J. ELSEVIER, 2019, the international journal for experimental and clinical reproductive immunobiology, Oxford |
|---|---|
| Übergeordnetes Werk: |
volume:113 ; year:2016 ; pages:54-60 ; extent:7 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.jri.2015.12.001 |
|---|
| Katalog-ID: |
ELV02951066X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV02951066X | ||
| 003 | DE-627 | ||
| 005 | 20230623201513.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180603s2016 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jri.2015.12.001 |2 doi | |
| 028 | 5 | 2 | |a GBVA2016004000003.pica |
| 035 | |a (DE-627)ELV02951066X | ||
| 035 | |a (ELSEVIER)S0165-0378(15)30057-7 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 084 | |a 35.00 |2 bkl | ||
| 084 | |a 44.46 |2 bkl | ||
| 100 | 1 | |a Meuleman, Tess |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| 264 | 1 | |c 2016 | |
| 300 | |a 7 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. | ||
| 650 | 7 | |a LMWH |2 Elsevier | |
| 650 | 7 | |a HELLP |2 Elsevier | |
| 650 | 7 | |a IUGR |2 Elsevier | |
| 650 | 7 | |a IQR |2 Elsevier | |
| 650 | 7 | |a MCP |2 Elsevier | |
| 650 | 7 | |a LUMC |2 Elsevier | |
| 650 | 7 | |a SLE |2 Elsevier | |
| 700 | 1 | |a Cohen, Danielle |4 oth | |
| 700 | 1 | |a Swings, Godelieve M.J.S. |4 oth | |
| 700 | 1 | |a Veraar, Kimberly |4 oth | |
| 700 | 1 | |a Claas, Frans H.J. |4 oth | |
| 700 | 1 | |a Bloemenkamp, Kitty W.M. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Oxford University Press |a Georgievska, J. ELSEVIER |t The use of serum marker CA-125 in patients operated because of endometriosis |d 2019 |d the international journal for experimental and clinical reproductive immunobiology |g Oxford |w (DE-627)ELV002243032 |
| 773 | 1 | 8 | |g volume:113 |g year:2016 |g pages:54-60 |g extent:7 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jri.2015.12.001 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 912 | |a SSG-OLC-PHA | ||
| 936 | b | k | |a 35.00 |j Chemie: Allgemeines |q VZ |
| 936 | b | k | |a 44.46 |j Klinische Pathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 113 |j 2016 |h 54-60 |g 7 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
t m tm |
|---|---|
| matchkey_str |
meulemantesscohendanielleswingsgodelieve:2016----:nraecmlmncdeoiinthmtraftlnefciuepa |
| hierarchy_sort_str |
2016 |
| bklnumber |
35.00 44.46 |
| publishDate |
2016 |
| allfields |
10.1016/j.jri.2015.12.001 doi GBVA2016004000003.pica (DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Meuleman, Tess verfasserin aut Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier Cohen, Danielle oth Swings, Godelieve M.J.S. oth Veraar, Kimberly oth Claas, Frans H.J. oth Bloemenkamp, Kitty W.M. oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:113 year:2016 pages:54-60 extent:7 https://doi.org/10.1016/j.jri.2015.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 113 2016 54-60 7 045F 610 |
| spelling |
10.1016/j.jri.2015.12.001 doi GBVA2016004000003.pica (DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Meuleman, Tess verfasserin aut Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier Cohen, Danielle oth Swings, Godelieve M.J.S. oth Veraar, Kimberly oth Claas, Frans H.J. oth Bloemenkamp, Kitty W.M. oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:113 year:2016 pages:54-60 extent:7 https://doi.org/10.1016/j.jri.2015.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 113 2016 54-60 7 045F 610 |
| allfields_unstemmed |
10.1016/j.jri.2015.12.001 doi GBVA2016004000003.pica (DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Meuleman, Tess verfasserin aut Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier Cohen, Danielle oth Swings, Godelieve M.J.S. oth Veraar, Kimberly oth Claas, Frans H.J. oth Bloemenkamp, Kitty W.M. oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:113 year:2016 pages:54-60 extent:7 https://doi.org/10.1016/j.jri.2015.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 113 2016 54-60 7 045F 610 |
| allfieldsGer |
10.1016/j.jri.2015.12.001 doi GBVA2016004000003.pica (DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Meuleman, Tess verfasserin aut Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier Cohen, Danielle oth Swings, Godelieve M.J.S. oth Veraar, Kimberly oth Claas, Frans H.J. oth Bloemenkamp, Kitty W.M. oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:113 year:2016 pages:54-60 extent:7 https://doi.org/10.1016/j.jri.2015.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 113 2016 54-60 7 045F 610 |
| allfieldsSound |
10.1016/j.jri.2015.12.001 doi GBVA2016004000003.pica (DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 DE-627 ger DE-627 rakwb eng 610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Meuleman, Tess verfasserin aut Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage 2016 7 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier • C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier Cohen, Danielle oth Swings, Godelieve M.J.S. oth Veraar, Kimberly oth Claas, Frans H.J. oth Bloemenkamp, Kitty W.M. oth Enthalten in Oxford University Press Georgievska, J. ELSEVIER The use of serum marker CA-125 in patients operated because of endometriosis 2019 the international journal for experimental and clinical reproductive immunobiology Oxford (DE-627)ELV002243032 volume:113 year:2016 pages:54-60 extent:7 https://doi.org/10.1016/j.jri.2015.12.001 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 35.00 Chemie: Allgemeines VZ 44.46 Klinische Pathologie VZ AR 113 2016 54-60 7 045F 610 |
| language |
English |
| source |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:113 year:2016 pages:54-60 extent:7 |
| sourceStr |
Enthalten in The use of serum marker CA-125 in patients operated because of endometriosis Oxford volume:113 year:2016 pages:54-60 extent:7 |
| format_phy_str_mv |
Article |
| bklname |
Chemie: Allgemeines Klinische Pathologie |
| institution |
findex.gbv.de |
| topic_facet |
LMWH HELLP IUGR IQR MCP LUMC SLE |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| authorswithroles_txt_mv |
Meuleman, Tess @@aut@@ Cohen, Danielle @@oth@@ Swings, Godelieve M.J.S. @@oth@@ Veraar, Kimberly @@oth@@ Claas, Frans H.J. @@oth@@ Bloemenkamp, Kitty W.M. @@oth@@ |
| publishDateDaySort_date |
2016-01-01T00:00:00Z |
| hierarchy_top_id |
ELV002243032 |
| dewey-sort |
3610 |
| id |
ELV02951066X |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02951066X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201513.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2015.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02951066X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(15)30057-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meuleman, Tess</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LMWH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HELLP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IUGR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IQR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LUMC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SLE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Danielle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Swings, Godelieve M.J.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veraar, Kimberly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claas, Frans H.J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bloemenkamp, Kitty W.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:113</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:54-60</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2015.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">113</subfield><subfield code="j">2016</subfield><subfield code="h">54-60</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Meuleman, Tess |
| spellingShingle |
Meuleman, Tess ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| authorStr |
Meuleman, Tess |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV002243032 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health 540 - Chemistry & allied sciences |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE Elsevier |
| topic |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE |
| topic_unstemmed |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE |
| topic_browse |
ddc 610 ddc 540 bkl 35.00 bkl 44.46 Elsevier LMWH Elsevier HELLP Elsevier IUGR Elsevier IQR Elsevier MCP Elsevier LUMC Elsevier SLE |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
d c dc g m s gm gms k v kv f h c fh fhc k w b kw kwb |
| hierarchy_parent_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| hierarchy_parent_id |
ELV002243032 |
| dewey-tens |
610 - Medicine & health 540 - Chemistry |
| hierarchy_top_title |
The use of serum marker CA-125 in patients operated because of endometriosis |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV002243032 |
| title |
Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| ctrlnum |
(DE-627)ELV02951066X (ELSEVIER)S0165-0378(15)30057-7 |
| title_full |
Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| author_sort |
Meuleman, Tess |
| journal |
The use of serum marker CA-125 in patients operated because of endometriosis |
| journalStr |
The use of serum marker CA-125 in patients operated because of endometriosis |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology 500 - Science |
| recordtype |
marc |
| publishDateSort |
2016 |
| contenttype_str_mv |
zzz |
| container_start_page |
54 |
| author_browse |
Meuleman, Tess |
| container_volume |
113 |
| physical |
7 |
| class |
610 610 DE-600 540 610 VZ 35.00 bkl 44.46 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Meuleman, Tess |
| doi_str_mv |
10.1016/j.jri.2015.12.001 |
| dewey-full |
610 540 |
| title_sort |
increased complement c4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| title_auth |
Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| abstract |
• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. |
| abstractGer |
• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. |
| abstract_unstemmed |
• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
| title_short |
Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage |
| url |
https://doi.org/10.1016/j.jri.2015.12.001 |
| remote_bool |
true |
| author2 |
Cohen, Danielle Swings, Godelieve M.J.S. Veraar, Kimberly Claas, Frans H.J. Bloemenkamp, Kitty W.M. |
| author2Str |
Cohen, Danielle Swings, Godelieve M.J.S. Veraar, Kimberly Claas, Frans H.J. Bloemenkamp, Kitty W.M. |
| ppnlink |
ELV002243032 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1016/j.jri.2015.12.001 |
| up_date |
2024-07-06T21:39:14.060Z |
| _version_ |
1803867341781467136 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV02951066X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623201513.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2016 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.jri.2015.12.001</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2016004000003.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV02951066X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0165-0378(15)30057-7</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.00</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.46</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Meuleman, Tess</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Increased complement C4d deposition at the maternal-fetal interface in unexplained recurrent miscarriage</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2016</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">• C4d is increased on trophoblast tissue in unexplained recurrent miscarriage. • Increase of C4d may reflect anti-fetal immunity in women with recurrent miscarriage. • Knowledge of this pathogenic mechanism may lead to new treatment strategies.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LMWH</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HELLP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IUGR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">IQR</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MCP</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">LUMC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">SLE</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cohen, Danielle</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Swings, Godelieve M.J.S.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Veraar, Kimberly</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claas, Frans H.J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bloemenkamp, Kitty W.M.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Oxford University Press</subfield><subfield code="a">Georgievska, J. ELSEVIER</subfield><subfield code="t">The use of serum marker CA-125 in patients operated because of endometriosis</subfield><subfield code="d">2019</subfield><subfield code="d">the international journal for experimental and clinical reproductive immunobiology</subfield><subfield code="g">Oxford</subfield><subfield code="w">(DE-627)ELV002243032</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:113</subfield><subfield code="g">year:2016</subfield><subfield code="g">pages:54-60</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.jri.2015.12.001</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.00</subfield><subfield code="j">Chemie: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.46</subfield><subfield code="j">Klinische Pathologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">113</subfield><subfield code="j">2016</subfield><subfield code="h">54-60</subfield><subfield code="g">7</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.403097 |